文献
J-GLOBAL ID:201202293094629092
整理番号:12A0380766
確証的慢性痛臨床試験のための調査設計検討:IMMPACT勧告
Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations
著者 (39件):
DWORKIN R.H.
(Univ. Rochester School of Medicine and Dentistry, NY, USA)
,
PEIRCE-SANDNER S.
(Univ. Rochester School of Medicine and Dentistry, NY, USA)
,
TURK D.C.
(Univ. Washington, WA, USA)
,
BARON R.
(Univ. Kiel, Kiel, DEU)
,
BELLAMY N.
(Univ. Queensland, Brisbane, AUS)
,
BURKE L.B.
(United States Food and Drug Administration, MD, USA)
,
COSTELLO A.
(United States Food and Drug Administration, MD, USA)
,
HERTZ S.
(United States Food and Drug Administration, MD, USA)
,
RAPPAPORT B.A.
(United States Food and Drug Administration, MD, USA)
,
CHAPPELL A.
(Eli Lilly and Co., IN, USA)
,
CHARTIER K.
(United BioSource Corp., PA, USA)
,
CLEELAND C.S.
(M.D. Anderson Cancer Center, TX, USA)
,
COWAN P.
(American Chronic Pain Assoc., CA, USA)
,
DIMITROVA R.
(Allergan, Inc, CA, USA)
,
ELLENBERG S.
(New York Univ., New York, NY, USA)
,
FARRAR J.T.
(New York Univ., New York, NY, USA)
,
FRENCH J.A.
(New York Univ., New York, NY, USA)
,
GILRON I.
(Queen’s Univ., Ont., CAN)
,
JADAD A.R.
(Univ. Toronto, Toronto, CAN)
,
JAY G.W.
(Schwarz Biosciences, NC, USA)
,
KALLIOMAKI J.
(AstraZeneca, Soedertaelje, SWE)
,
KATZ N.P.
(Analgesic Res., MA, USA)
,
KERNS R.D.
(Dep. of Veterans Affairs, CT, USA)
,
MANNING D.C.
(Celgene Corp., NJ, USA)
,
MCDERMOTT M.P.
(Univ. Rochester, NY, USA)
,
MCGRATH P.J.
(Dalhousie Univ., NS, CAN)
,
NARAYANA A.
,
PORTER L.
,
WITTER J.
,
QUESSY S.
,
RAUSCHKOLB C.
,
REEVE B.B.
,
RHODES T.
,
SAMPAIO C.
,
SIMPSON D.M.
,
STAUFFER J.W.
,
STUCKI G.
,
TOBIAS J.
,
WHITE R.E.
資料名:
Pain
(Pain)
巻:
149
号:
2
ページ:
177-193
発行年:
2010年05月
JST資料番号:
A1182A
ISSN:
0304-3959
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)